반응형
This is our fourth update on the recently released draft standard for medical device labeling published by Mexico’s medical device regulator COFEPRIS, NOM-137-SSA1-2024.
Background on NOM-137-SSA1-2024
COFEPRIS released (March 12) a new draft of the NOM for Medical Device labeling, NOM-137-SSA1-2024. We posted part 2 and part 3, to further clarify the proposed medical device labeling standard. In this last part, we discuss the new symbols and share the descriptions.
Identification of the medical device manufacturer
The most remarkable changes in this draft are:
- The explanation that the country of origin of the medical device is not to be confused with the real manufacturer, which may differ. The country of origin was required in the previous NOM and while it has not been officially defined to date, it is understood to be where the devices are shipped from before import into Mexico.
- Abbreviations are now permitted within the address.
- Medical devices imported as samples must be identified according to the manufacturer’s QMS and shall include the statement “Prohibited for sale”.
Mexico COFEPRIS Announces Revised Labeling Standard | Emergo by UL
반응형
'교육 세미나 전시' 카테고리의 다른 글
[한국의료기기협동조합] 2024 경기도 해외시장 진출 해외인증 FDA, MDSAP 이해 세미나 참여기업 모집 (0) | 2024.05.27 |
---|---|
2024년 의료기기 국제인증지원사업 2차 공고_해외인증 심사비 지원 (0) | 2024.05.24 |
[공청회] 범부처전주기의료기기연구개발사업 후속사업 기획 제1차 공청회 (0) | 2024.05.13 |
[Emergo, UL] Webinar: Medical Device Software and Cybersecurity (0) | 2024.05.07 |
[Emergo, UL] Webinar: Revised IVD Regulation RDC 830/2023 (0) | 2024.05.07 |